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Summary
Objective: To assess osteoarthritis (OA) association with the human interleukin-1 (IL-1) region.
Design: Sixty-four European-descent cases with radiographic hand OA and 48 European-descent controls were genotyped at nine single
nucleotide polymorphism (SNP), one variable-number-of-tandem-repeat (VNTR), and one microsatellite marker extending across loci for
IL-1a (IL1A), IL-1b (IL1B), and IL-1 receptor antagonist (IL1RN). The genotype data were used to reconstruct individual locus haplotypes,
and then locus haplotypes were used as superalleles for extended haplotype reconstruction.
Results: Nine different extended IL1AeIL1BeIL1RN haplotypes occurred at a frequency 0.05 or greater in either cases or controls. Only two
IL1AeIL1BeIL1RN extended haplotypes were consistent with previously described extended risk haplotypes and totaled n¼ 9 in cases and
n¼ 3 in controls [odds ratio (OR) 2.1, Haldane’s c2 1.67, one-sided P 0.1]. Our prior report showed hand OA association with homozygous
IL1B rs1143633 minor allele genotype. All except one extended risk haplotype copy also had the IL1B rs1143633 minor allele. The rs1143633
genotype association was explained by one common six-SNP IL1B haplotype bearing rs1143633 minor allele and also risk alleles at
rs1143634, rs1143627, and rs16944, component markers of the previously described extended risk haplotypes. The IL1B haplotype bearing
all three risk alleles was found in 16 haplotype-homozygous hand OA cases and in four haplotype-homozygous controls and conferred OR 3.4
among homozygotes (nominal P value 0.006).
Conclusion: Our evidence broadly supports the genetic association of OA phenotypes with an IL-1 region extended risk haplotype and spe-
ciﬁcally IL1B genotype. The extended risk haplotype previously associated with hip OA appears to be less frequent and has weaker genetic
effect in hand OA. Hand OA risk is conferred by homozygous state for the IL1B haplotype characteristic of the extended risk haplotype.
ª 2007 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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SocietyIntroduction
Osteoarthritis (OA) is a late-onset disorder that shows clinical
heterogeneity in joint numbers and regions involved. Some
patients have one or a small number of involved joints (hip,
knee, or hand OA alone), while others have clustered joint
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Received 12 December 2006; revision accepted 29 March 2007.1regions affected in a characteristic distribution (generalized
OA). Current understanding about whyOA occurs is summa-
rized in a working model postulating that OA emanates from
interaction between ‘‘systemic’’ risk factors and local ‘‘biome-
chanical’’ effects1,2. Heredity is an important ‘‘systemic’’ risk
factor3e5. Familial aggregation6e9 and higher monozygotic
than dizygotic twin concordance10 support the notion that ge-
netic factors play a major role in etiology. Hand OA, largely
mirroring the primary generalized OA variant, is more herita-
ble than hip or knee OA (broad-sense heritability estimates
0.65 hand vs 0.39 knee10 or 0.41 hip11). For spine disease,
the heritability is even higher, up to 0.7412. Deﬁning heritable
factors conferring OA liability and variation may be important
to devising future prevention and therapy.
Interleukin-1 (IL-1) has a pivotal biological role in early
and late stages of experimental OA. Current information en-
twines IL-1 with detrimental OA mechanisms (reviewed in
Refs. 13e16). OA-affected cartilage bears ﬁndings consis-
tent with a deleterious imbalance between IL-1 and its con-
trol proteins17,18. Blocking IL-1 prevents OA in animals19e22106
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control comparison of in vitro innate immunity showed that
human subjects with the highest quartile of lipopolysaccha-
ride-stimulated IL-1b (IL1B) and IL-1Ra had an increased
OA risk, consistent with the notion that variations in innate
cytokine production may inﬂuence OA liability26. Taken as
a whole, this body of evidence suggests that IL-1 region
genes are appropriate biological candidates.
We showed an association of hand OA, particularly a se-
vere subtype with erosive hand OA, with a homozygous
genotype for IL1B rs1143633 minor allele [overall odds ratio
(OR) 2.58, P 0.02]27. Since then, research groups at Leiden
and Bristol have described hip OA association with an ex-
tended IL-1 region haplotype, deﬁned ﬁrst as a three-marker
haplotype with two IL1B single nucleotide polymorphism
(SNP) major alleles at rs1143634 and rs16944, and an IL-1
receptor antagonist (IL1RN) variable-number-of-tandem-
repeat (VNTR) *2 minor allele (haplotype designated 1-1-2)28,
and later as a seven- or eight-marker haplotype across IL-
1a (IL1A), IL1B, and IL1RN loci29,30. The IL1A-IL1RN region
is best termed an ‘‘extended’’ haplotype because it stretches
across >350 kb, 10 haplotype blocks of preserved linkage
disequilibrium (LD), and nine distinct IL-1-related loci. Using
n¼ 22 severe hipOAcases, Smith et al. described strong ge-
netic effect for theeight-marker IL1AeIL1BeIL1RNextended
haplotype (OR 23)30. With n¼ 70 hip OA cases, Meulenbelt
et al. found association with a seven-marker haplotype con-
sistent with the Smith extended risk haplotype (OR 7.3)29.
The difference between the seven-marker and eight-marker
extended haplotypes is an extra IL1A (TTA)n microsatellite
allele that Smith’s typing panel included but Meulenbelt’s
did not. Thus, three research groups have supported IL-1
region association with one or another OA phenotype in
European-descent panels27e31.
Finding a genomic region likely to contain pathogenic var-
iants will be a big step toward explaining OA pathogenesis.
We therefore examined additional markers that deﬁne the
extended risk haplotypes and genotypes among our previ-
ously studied hand OA cases and controls.
Methods
HUMAN SUBJECTS
This is the same caseecontrol panel identiﬁed and re-
cruited as outlined in our previous study27. Brieﬂy, European-
descent hand OA subjects and European-descent controls
represented outpatients aged 60 years and older. We
deﬁned phenotype by questionnaire, joint examination,
and hand radiographs if American College of Rheumatology
Clinical Criteria for Hand Osteoarthritis were present32.
Hand OA was classiﬁed by KellgreneLawrence radio-
graphic criteria with affected being grade 2 or higher33
and divided into erosive or non-erosive hand OA subsets
by a deﬁnition of typical erosive changes in three or more
digits. The erosive hand OA subset had quite severe
hand OA with mean 15.9 SD 4.1 joints radiographically
affected and 15.0 4.0 nodes on examination; the non-
erosive hand OA subset had 7.5 5.4 joints radiographi-
cally affected and 9.6 4.2 nodes (for additional details,
see Ref. 32). Peripheral blood DNA was puriﬁed using the
salting-out method as previously detailed.
GENOTYPING
Genotyping for rs1800587 (IL1A 889), IL1B rs1143634
(IL1B þ3954), rs1143633 (IL1B 5810), rs1143627(IL1B 31), and rs16944 (IL1B 511), and IL1RN
rs419598 (IL1RN 8006), intron 2 VNTR, and rs315952
(IL1RN 11100) was done as previously outlined27. IL1A
(TTA)n genotyping was performed by polymerase chain
reaction (PCR) ampliﬁcation followed by denaturing poly-
acrylamide gel electrophoresis and silver staining. IL1B
rs3917368 and rs3917356 typing were performed using
Taqman SNP genotyping assays (Applied Biosystems,
Foster City, CA). All genotypes of controls were in Har-
dyeWeinberg equilibrium (HWE); the OA panel showed de-
viation from HWE for IL1B rs1143633 (P 0.001) and IL1RN
rs49598 and VNTR (P values 0.004 and 0.032, respec-
tively). Because too many missing genotypes may render
statistical reconstruction of haplotypes inaccurate, four OA
subjects and three controls with several missing genotypes
due to technical failures were excluded. For this reason, the
subject numbers were smaller than those previously re-
ported (previously n¼ 68 hand OA and n¼ 51 controls,
for this study n¼ 64 hand OA and n¼ 48 controls).
STATISTICS
LD patterns were analyzed using Haploview (http://
www.broad.mit.edu/mpg/haploview/). To allow haplotype
and then extended haplotype analysis, we reconstructed lo-
cus haplotypes ﬁrst and then used locus haplotypes as
superalleles to reconstruct extended haplotypes for each
subject. Statistical reconstruction was done using PHASE
v2.1, which employs a Markov Chain Monte Carlo algo-
rithm34,35. Brieﬂy, two-marker genotype data were used to
construct IL1A haplotypes, six-marker genotype data were
used for IL1B, and three-marker genotype data were used
for IL1RN. Haplotype ORs were calculated using Haldane’s
modiﬁcation of Wolff’s relative risk36, and genotype ORs
were calculated using Lathrop’s method37. Cathryn Lewis’s
method was used to assess genetic models with the addi-
tion of adjusting controls to ﬁt HWE38. HWE was tested us-
ing linkage utility software (ftp://linkage.rockefeller.edu/
software/utilities).
Results
EXTENDED IL1AeIL1BeIL1RN RISK HAPLOTYPE
Using Haploview analyses, LD between the two IL1A
markers was measured as D0 0.881, between the most dis-
tant IL1B SNP pair (rs1917368 and rs16944) D0 1.0, and be-
tween the two IL1RN SNP loci D0 0.79. The inter-locus LD
was lower between IL1A and IL1B and between IL1B and
IL1RN (between IL1A rs1800587 and IL1B rs3917368 D 0
0.558, and between IL1B rs16944 and IL1RN rs419598
D 0 0.583). The pattern of higher LD within loci and lower
LD between loci supported the strategy of reconstructing
locus haplotypes ﬁrst and then using locus haplotypes as
superalleles to reconstruct extended haplotypes. The total
number of IL1AeIL1BeIL1RN extended haplotypes among
cases and controls is n¼ 33, consistent with a large region
that shows ancestral recombination and in contrast to a sin-
gle large haplotype block with preserved LD (Table I). In our
hand OA cases and controls, no extended haplotype
matched the eight-marker haplotype described by Smith
et al. exactly30. The seven-marker extended risk haplotype
(without the IL1A (TTA)n marker) that Meulenbelt et al.
found29 was present on two different extended haplotypes
(designated haplotypes 17 and 20, boxed in Table I). Using
aggregate numbers in Table I for the two seven-marker risk
haplotypes, the genetic effect size was quite modest (OR
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IL-1 region extended haplotypes with hand OA
IL1A IL1B IL1RN 
 
21 x1xx11 221
x1 x1xx11 221
xx x1xxx1 x2x
21
221
221
21 221
221
221
Extended risk haplotype 
8-marker haplotype 30
(hip OA) 
7-marker haplotype 29
(hip OA) 
1-1-2 risk haplotype 28
(hip OA) 
Extended haplotype IL1A IL1B IL1RN 
3
11 11  
24 12  
1
28 12  111 
29 12  112 
17 11  
21 11  
22 11  
20 11
Other 23 infrequent 
extended haplotypes 
Case (of n = 128 
haplotypes)  
Control (of n = 96 
haplotypes 
111122
211211
212211
212211
212211
111122 
111122 
121111 
121111 
111122 111 0.031 0.073 
0.016 0.073 
0.023 0.052 
0.164 0.094 
0.008 0.000 
111 0.164 0.188 
112 0.078 0.052 
0.063 0.031 
0.102 0.042 
0.086 0.052 
0.320 0.417 
Haplotypes are designated by loci with major allele 1 and minor allele(s) 2 (or 3). The marker loci include: IL1A (TTA)n and rs1800587, IL1B
rs391736, rs1143634, rs1143633, rs391735, rs1143627, and rs16944, and IL1RN rs419598, VNTR, and rs315952. The component haplo-
types at each locus along the eight-marker extended risk haplotype are shown by white numbers on shaded background. Haplotypes
most consistent with the seven-marker risk haplotype are boxed. Three-marker IL1BeIL1RN haplotype 1-1-2 is shown by haplotypes bearing
bold alleles (17 and 20). The IL1B rs1143633 is the third-from-left position in the six IL1B markers, with the minor allele underlined.2.1, Haldane’s c2 1.67, one-sided P 0.1 with case frequency
0.064 and control frequency 0.031). No other extended
haplotypes bore the IL1BeIL1RN 1-1-2 risk haplotypedthe
1-1-2 haplotype was entirely congruent with the seven-
marker extended risk haplotype.
EXTENDED IL1AeIL1BeIL1RN HAPLOTYPES BEARING THE
HAND OA RISK ALLELE IL1B RS1143633 MINOR ALLELE
We had previously described that IL1B rs1143633 geno-
types deviated from HWE in hand OA cases and found as-
sociation of hand OA with the homozygous IL1B rs1143633
minor allele genotype, particularly in the more severe sub-
set with erosive hand OA27. To reﬁne this association, we
examined extended IL1AeIL1BeIL1RN haplotypes bearing
the IL1B rs1143633 minor allele. Nine of 33 extended hap-
lotypes had the IL1B rs1143633 minor allele, of which only
three were common (extended haplotypes 21, 22, and 20)
(Table I). Haplotype 20 has the IL1B rs1143633 minor allele
and is consistent with the extended risk haplotype previ-
ously described with hip OA.IL1A, IL1B, AND IL1RN HAPLOTYPES BEARING COMPONENT
MARKERS OF THE HIP OA EXTENDED RISK HAPLOTYPE
The IL1A and IL1RN loci showed little difference between
our hand OA cases and controls for either haplotypes or ge-
notypes. For IL1B, the most common haplotype (designated
IL1B haplotype 7) had the risk marker major alleles at
rs1143634, rs1143627, and rs16944 as well as the IL1B
rs1143633 minor allele (Table II). IL1B haplotype 7 was
consistent with either the previously described eight-marker
or seven-marker extended risk haplotype. The enrichment
of IL1B rs1143633 minor allele homozygotes in hand OA
cases we had previously described27 was almost entirely
accounted for by homozygotes for haplotype 7, with
n¼ 16 cases and n¼ 4 controls. Another 19 cases and
23 controls were haplotype 7 heterozygotes. Among
n¼ 23 subjects in the erosive subset of hand OA, the
IL1B haplotype 7 homozygotes numbered eight, and an-
other seven were heterozygotes. Using Lathrop’s method
for genotype relative risk on all hand OA subjects, the
strength of genetic effect was OR 3.39 among IL1B haplo-
type 7 homozygotes (P 0.006). With the Lewis method for
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IL1B locus haplotypes
IL1B markers 
rs3917368 rs1143634 rs1143633 rs3917356 rs1143627 rs16944 
Alternative names +3954, 5887 5810 -31, 1903 -511, 1423
Major > minor allele G>A C>T G>A G>A T>C G>A, C>T 
IL1B haplotype Case Control 
1 1 1 1 1 2 2
2 1 1 1 1 1 1
3 1 1 2 1 2 2
4 1 2 1 1 2 2
5 1 2 1 1 1 1
6 2 1 1 2 1 1
7 2 1 2 2 1 1
8 2 2 1 2 1 1
0.297
0.008
0.016
0.008
0.203
0.070
0.398
0.000
0.354
0.021
0.021
0.021
0.167
0.063
0.323
0.031
IL1B haplotype 7 (shaded) is consistent with either the seven-marker or eight-marker extended risk haplotype and bears IL1B rs1143633
minor allele29,30.examining various genetic models, the distribution of IL1B
risk haplotypes appears to ﬁt a recessive model (P w0.05)
and not dominant, multiplicative, or additive models
(P values 0.955, 0.246, and 0.446, respectively).
Discussion
Our hand OA data are broadly consistent with two previ-
ous studies showing hip OA association with an extended
risk haplotype stretching across the IL1A, IL1B, and
IL1RN loci. The IL1B rs1143633 minor allele we found to
confer hand OA risk is also on the extended risk haploty-
pedbut not speciﬁc for itdand the IL1B rs1143633 minor
allele homozygous genotype association with hand OA ap-
pears to be accounted for by subjects homozygous across
an IL1B region bearing markers consistent with the ex-
tended IL1AeIL1BeIL1RN risk haplotype. One should not
over-interpret this as a dramatic new ﬁnding or conﬁrmation,
because no new subjects were studied. The study does
provide some support and suggests another manner of
comparison by locus, haplotype, and genotype.
To favor ﬁnding a pathogenic variant, one would aim to
describe a single risk haplotype explaining the pattern of in-
dividual marker associations and bearing each associated
marker allele. From several association studies, one may
discern some evidence consistent with a single extended
IL1AeIL1BeIL1RN OA risk haplotype in European-descent
populations28e31,39 (Table III). With this study and the Bris-
tol and Leiden reports, we have largely congruent evi-
dence, admittedly with different index phenotypes (hip OA
vs hand OA) and some unexplained conﬂicts about fre-
quency and genetic effect size. Meulenbelt’s researchgroup at Leiden found that the hip OA frequency difference
in IL1BeIL1RN haplotype 1-1-2 was case 0.16dcontrol
0.0728. Smith et al. at Bristol conﬁrmed three-marker
haplotype 1-1-2 association with hip OA with frequency dif-
ference of case 0.23dcontrol 0.10730. Smith et al. also de-
scribed the eight-marker IL1AeIL1BeIL1RN extended risk
haplotype with frequency difference of case 0.205dcontrol
0.0130. We found a difference from Smith’s extended
haplotype, IL1A (TTA)n allele *1 instead of *2. Because
changes at microsatellite repeat markers arise more
frequently in evolutionary time40, we reason that a simple
difference in IL1A (TTA)n allele at one end of an otherwise
identical extended haplotype would not necessarily repre-
sent a conﬂict. Meulenbelt’s group at Leiden found
a seven-marker IL1AeIL1BeIL1RN extended haplotype
1-111-221 consistent with the Bristol eight-marker risk hap-
lotype (underlined alleles are the three IL1BeIL1RN ex-
tended haplotype markers)29. Using a different index
phenotype (hand OA), we ﬁnd lower case and control
1-1-2 frequencies than either Bristol or Leiden panels; our
caseecontrol difference was 0.0625d0.0319. Next, in
comparison with this study, both Bristol and Leiden groups
found higher ORs with the seven- or eight-marker haplo-
type than with the three-marker IL1BeIL1RN 1-1-2. The
Bristol group reported ﬁve cases and 38 controls who
had the 1-1-2 haplotype but not the extended eight-marker
risk haplotype, and the Leiden observation of higher OR for
IL1AeIL1BeIL1RN extended risk haplotype than for the
three-marker 1-1-2 haplotype is consistent with a similar
distribution phenomenon. In contrast, we found complete
overlap between subjects who had 1-1-2 and the full
seven-marker extended haplotype. Another study from Ber-
lin is also somewhat consistent with the single extended
1110 G. Moxley et al.: IL-1 Region association with hand OATable III
Summary about potential IL1AeIL1BeIL1RN extended risk haplotypey
IL1A IL1B IL1RN
IL1A-IL1B-IL1RN extended risk haplotype‡ rs or name(TTA)n 1800587 1143634 1143633 1143627 16944 419598 VNTR 454078 315952
alias  -889 +3953 5810 -31 -511 8006ª VNTRª +9589 11100 
Study Phenotype 
Mean age 
cs/cntrl
n OA ht OR
Smith 30 hip (THA) 71/(18-55) 22 2 1 1 1 1 2 2 1 23.0*
71/(18-55) 22 1 1 2 3.90*
Meulenbelt 29 hip ROA 61/60 70 1 1 1 1 2 2 1 7.30*
Meulenbelt 28 hip ROA 61/60 70 1 1 2 3.05*
Current study hand ROA 69/70 64 1 1 1 1 2 2 1 2.10
Chapman 42 hip (THA) 73/73 370 1 1 (2) 2 1.00
SNP OR VNTR OR
Moos 39 (THA/TKA) 70.4/(18-55) 65 2 5.10* 2 3.84* 
Meulenbelt 28 hand ROA 62/60 38 1 1.19 1 1.18 2 2.08 
knee ROA 61/60 139 1 0.90 1 1.24 2 0.90 
aIL1RN VNTR and IL1RN rs419598 markers reversed from Smith et al. description30 to conform with chromosomal position. yThis table
summarizes various study results related to IL-1 region extended risk haplotype. The second column denotes index phenotype (ROA, radio-
graphic OA; THA, total hip arthroplasty; TKA, total knee arthroplasty) and potential confounders (N secondary OA, #; early ascertainment
age), the third lists mean age of subjects (cs, case; cntrl, control), and the fourth column the OA sample size. The marker haplotypes are
designated by shaded bars bearing major or minor alleles for IL-1 markers noted at top. [Chapman IL1RN VNTR allele (in parentheses)
was inferred by LD.] ORs are listed in the last column for haplotypes or beside each individual marker. *Indicates OR [haplotype (ht) or
homozygous marker genotype] with P< 0.01 or smaller.risk haplotype with the IL1RN VNTR *239. Occurrence of
marker alleles on more than one common haplotype may
explain lower ORs with individual markers. In our panel,
counting only those haplotypes with frequency 0.05 or
greater, the IL1B rs1143634 major allele is found on three
common IL1B haplotypes total and seven common ex-
tended haplotypes, the IL1B rs16944 major allele on three
common IL1B haplotypes and ﬁve common extended hap-
lotypes, and the IL1RN VNTR *2 allele on only one com-
mon IL1RN haplotype and four common extended
haplotypes. Moos et al. showed signiﬁcant association of
severe hip and knee OA with IL1RN VNTR *2 but also
a conﬂicting association with the IL1B rs1143634 minor al-
lele39. Clinical heterogeneity and incomplete penetrance
might explain the apparently conﬂicting association with
the IL1B rs1143634 minor allele. Another explanatory fac-
tor may be ancestral recombination toward one end of
this extended risk haplotype, present in the Berlin Euro-
pean-descent panel but not in the others. A single, repli-
cated IL-1 region extended risk haplotype does not mean
that the OA picture is simpledone sees other apparent ef-
fects differing among studies. For example, Loughlin et al.
at Oxford ascertained knee OA by arthroplasty and found
marginal or negative results with most of the markers
used (borderline with IL1A rs1800587 and an IL1RN SNP
rs454078 in LD with IL1RN VNTR, and negative with
IL1B rs1143634, IL1B rs1143633, IL1B rs16944, and
IL1RN rs315952)41. Recently, the Oxford group reanalyzed
the data for relation of the extended IL1BeIL1RN 1-1-2
haplotype (by inferring the IL1RN VNTR *2 from LD
with rs454078 minor allele) to arthroplasty-ascertained hip
OA and found negative results42. The Oxford panel
has the outstanding virtue of large sample size and also
potential concerns about heterogeneity, severity bias, and
control classiﬁcation41. Also, Smith et al. found knee OAassociation with an extended IL1AeIL1BeIL1RN risk hap-
lotype differing from the hip OA haplotype, and a protective
IL1BeIL1RN haplotype31. Meulenbelt et al. reported an-
other three-marker risk haplotype (1-2-1) differing from
the 1-1-2, and also a possible protective haplotype (2-1-1)28.
Whether any marker or extended risk haplotype report dif-
ferent from the single extended risk haplotype is a true or
false positive cannot be distinguished at this timeda patho-
genic or protective variant might be on more than one risk
haplotype and not optimally deﬁned by a limited marker set
stretching over 300 kb. Overall, one must always be con-
cerned about the potential of false-positive studies, but
the data with the IL1BeIL1RN 1-1-2 and IL1AeIL1Be
IL1RN seven-marker extended haplotypes do not show
marginal statistical effects differing among studies as one
might expect with multiple false positives. Were these as-
sociations all false positives, one would not expect them
to point to one risk haplotype. Thus, with the speciﬁc notes
that the OA index phenotypes are not identical and the
Oxford group has negative results42, we conclude that
some evidence favors a single, replicable, signiﬁcantly
associated, extended IL-1 region risk haplotype with hip
and possibly hand OA phenotypes.
Despite the generally available knowledge about OA clin-
ical variants, investigative designs may not have addressed
OA phenotypes optimally. The Leiden study contrasted ra-
diographic-hip-OA-positives with hip-OA-negatives28,29.
This contrasting-index-joint design lends itself better to
examining local biomechanical and joint-speciﬁc genetic
factors than systemic liability. Next, the Bristol and Berlin
study designs were to contrast arthroplasty cases with
younger blood donor controls30,39. Arthroplasty-based
ascertainment involves a disease spectrum bias toward
severe involvement and clinical variant heterogeneity
including secondary OA with attendant potential to dilute
1111Osteoarthritis and Cartilage Vol. 15, No. 10statistical association. Using blood donor controls ascer-
tained at an age before a disorder typically occurs undoubt-
edly misclassiﬁes some subjects who are destined to
become cases (thus reducing statistical signal). The Oxford
caseecontrol panels were based on arthroplasty cases and
spouse controls who had not been treated for OA41dthis
design could potentially lead to case spectrum bias, case
heterogeneity, and control misclassiﬁcation because of
information bias. Thus, these phenotype and classiﬁcation
issues make the evidence supporting association with a sin-
gle IL-1 region extended haplotype all the more remarkable.
In conclusion, we ﬁndwithmore detailed examination of IL-
1 loci and haplotypes some supporting evidence that a single
extended haplotype deﬁned by IL-1 region markers confers
risk for hand OA. Our data suggest one IL1B risk haplotype
anda recessive geneticmodel. Larger independent samples,
study design to address optimal phenotype, and detailed
genotyping in this region will aid in discerning whether the
IL-1 region is likely to contain OA pathogenic variants.
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